Robert Weinstein - 02 Jun 2025 Form 4 Insider Report for XWELL, Inc. (XWEL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Jun 2025, 08:01:35 UTC
Prior SEC filing
12 Dec 2025
Next SEC filing
02 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Cara Soffer, Attorney-in-fact for Robert Weinstein

Key filing fact

Robert Weinstein filed Form 4 for XWELL, Inc. (XWEL) on 03 Jun 2025.

Key facts

  • This page summarizes Robert Weinstein's Form 4 filing for XWELL, Inc. (XWEL).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Jun 2025, 08:01.

Change

  • Previous filing in this sequence was filed on 12 Dec 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001213709 Primary reporting owner

WEINSTEIN ROBERT

Relationship
Director
Address
C/O XWELL, INC., 254 WEST 31ST STREET, 11TH FLOOR, NEW YORK
Signature
/s/ Cara Soffer, Attorney-in-fact for Robert Weinstein
Signature date
03 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XWEL transaction

Common Stock, par value $0.01

Award

Transaction value
Shares
+107,407
Change %
+1373%
Price
Shares after
115,231
Date
02 Jun 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XWEL transaction Derivative

Employee stock option (right to buy)

Award

Transaction value
$0
Shares
+117,886
Change %
Price
$0.000000
Shares after
117,886
Date
02 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
117,886
Exercise price
$0.9680
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reporting person received fully vested restricted stock units, in consideration of the reporting person's Board fees decrease effective in the fourth quarter of 2024.

Footnote F2

Represents stock options to purchase up to 117,886 shares of Common Stock with such stock options vesting 100% on the first anniversary of the date of the grant, provided that the reporting person is providing services to the Company through such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .